UK Regulator Issues Alert for Mirtazapine Tablets Due to Barcode Error

The UK's Medicines and Healthcare products Regulatory Agency has issued a Class 4 defect notification for a batch of Mirtazapine 30mg tablets. The issue stems from an incorrect barcode that misidentifies the product as a different medication when scanned. While the tablets' quality remains unaffected, healthcare professionals are advised to avoid automated dispensing systems for this batch and rely on manual checks.